Dr. Xie’s practice focuses on PRC-related cross-border merger and acquisition (M&A) (inbound investment into China and outbound investment from China), Chinese companies’ overseas IPO, anti-trust pre-merger filing in China, and corporate and commercial matters. With more than 15 years’ experience representing both domestic and foreign investors in PRC-related cross border transactions, Dr. Xie advises clients on a wide array of legal issues including, overseas investments by PRC individuals, state-owned or private enterprises, foreign direct investment, corporate restructuring, listings and other fund raising on overseas markets, private placement of securities, regulatory compliance of foreign investment enterprises in China, pre-merger filings in China and restructuring tax.
